Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ryota Kakizaki
Erratum To: Effects on Bone Metabolism Markers and Arterial Stiffness by Switching to Rivaroxaban From Warfarin in Patients With Atrial Fibrillation
Heart and Vessels
Cardiovascular Medicine
Cardiology
Related publications
Rivaroxaban Versus Warfarin in Nonvalvular Atrial Fibrillation
Yearbook of Cardiology
Patient Satisfaction After Switching From Warfarin to Apixaban in Patients With Nonvalvular Atrial Fibrillation: AGAIN Study
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Comparative Pharmacoeconomic Analysis of Rivaroxaban and Warfarin Usage in Patients With Non-Valvular Atrial Fibrillation
Jounal of arrhythmology
Hospital Length of Stay: Does Rivaroxaban Reduce Inpatient Stay Compared to Warfarin Among Patients With Non-Valvular Atrial Fibrillation?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Major Bleeding With Dabigatran and Rivaroxaban in Patients With Atrial Fibrillation
Clinical and Applied Thrombosis/Hemostasis
Medicine
Hematology
Role Fibrosis Markers to Stratify Risk of Atrial Fibrillation in Patients With Arterial Hypertension and Ekstakardialnoy Pathology
Современные проблемы науки и образования (Modern Problems of Science and Education)
PCV79 Compliance With Warfarin Therapy by Australian Patients With Atrial Fibrillation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Examining Warfarin Underutilization Rates in Patients With Atrial Fibrillation: Detailed Chart Review Essential to Capture Contraindications to Warfarin Therapy
Thrombosis Journal
Hematology
Noninvasive Surrogate Markers to Predict Thrombogenesis in Patients With Nonvalvular Atrial Fibrillation
Journal of Nihon University Medical Association
